Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring: a Multicenter, Prospective, Interventional Study

NCT07747701 is registered in ClinicalTrials.gov with Beijing Shijitan Hospital, Capital Medical University as lead sponsor.

NCT NCT07747701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07747701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring: a Multicenter, Prospective, Interventional Study
Lead sponsor
Beijing Shijitan Hospital, Capital Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
July 31, 2026
Completion date
February 5, 2027
Enrollment
227 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, cerebral autoregulation